Epizyme to Ring the NASDAQ Stock Market Closing Bell

Published: Aug 06, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ADVISORY, Aug. 6, 2013 (GLOBE NEWSWIRE) - What: Epizyme, Inc. [EPZM], a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, will visit the NASDAQ MarketSite in Times Square.

Help employers find you! Check out all the jobs and post your resume.

Back to news